BMO Capital: 'Trevi Therapeutics (TRVI) Stands Alone in RCC Following Nocion Study Failure' Oct 7, 2026 09:36AM
BMO Capital Starts Trevi Therapeutics (TRVI) at Outperform Jul 20, 2026 05:01PM
Trevi Therapeutics to Present at BMO Prescriptions for Success Healthcare Virtual Conference Jun 17, 2020 04:05PM
Trevi Therapeutics to Present at BMO Prescriptions for Success Healthcare Virtual Conference Jun 17, 2020 04:05PM
BMO Capital Starts Trevi Therapeutics (TRVI) at Outperform Jun 3, 2019 02:18AM


May 7, 2019 01:29PM Trevi Therapeutics (TRVL) Prices 5.5M Share IPO at $10/Sh
May 7, 2019 01:22PM Trevi Therapeutics Announces Pricing of Initial Public Offering